G1: ECMO, product that is being developed, will help patients with COVID-19
The Braile Biomédica is developing, in partnership with the Eldorado Institute and the Embrapii (Brazilian Enterprise of Industrial Research and Innovation), a pioneer product in Brazil for the COVID-19 treatment. It is a equipment that consists in a extracorporeal membrane oxygenation, ECMO, a way of extracorporeal breathing. It will be used as a support in the mechanical treatment, offering the patient an auxiliary lung in the case of the ventilation is not having an effect on treatment.